- Home
- FJDI vs INGN Comparison
FJDI vs INGN Comparison
Compare FJDI & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FJDI | INGN |
|---|---|---|
| Founded | 2025 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.4M | 177.5M |
| IPO Year | 2025 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FJDI | INGN |
|---|---|---|
| Price | $9.90 | $7.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 69.7K | ★ 330.0K |
| Earning Date | N/A | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | N/A | $2.22 |
| Revenue Next Year | N/A | $4.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $9.84 | $5.05 |
| 52 Week High | $9.90 | $9.03 |
Technical Indicators
Market Signals| Indicator | FJDI | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 71.20 | 74.61 |
| Support Level | $9.85 | $6.01 |
| Resistance Level | N/A | $7.04 |
| Average True Range (ATR) | 0.02 | 0.25 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 100.00 | 89.15 |
Price Performance
Historical ComparisonAbout FJDI ARC Group Securities Acquisition I Class A Ordinary Shares
ARC Group Securities Acquisition I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.